tiprankstipranks
Trending News
More News >
Ginkgo Bioworks Holdings (DNA)
NYSE:DNA
US Market

Ginkgo Bioworks Holdings (DNA) Income Statement

Compare
2,190 Followers

Ginkgo Bioworks Holdings Income Statement

Last quarter (Q4 2024), Ginkgo Bioworks Holdings's total revenue was $43.85M, an increase of 26.16% from the same quarter last year. In Q4, Ginkgo Bioworks Holdings's net income was $-107.53M. See Ginkgo Bioworks Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 227.04M$ 251.46M$ 477.71M$ 313.84M$ 76.66M
Gross Profit
$ 188.49M$ 197.45M$ 273.49M$ 184.15M$ 61.05M
Operating Expenses
$ 748.25M$ 1.06B$ 2.48B$ 2.01B$ 198.07M
Depreciation and Amortization
$ 63.02M$ 71.55M$ 61.63M$ 29.08M$ 13.86M
EBITDA
$ -484.39M$ -821.29M$ -2.06B$ -1.81B$ -108.58M
Operating Income
$ -559.76M$ -864.41M$ -2.21B$ -1.83B$ -137.03M
Other Income/Expenses
$ 12.25M$ -28.53M$ 87.55M$ -9.65M$ 12.19M
Pretax Income
$ -547.51M$ -892.94M$ -2.12B$ -1.84B$ -124.83M
Net Income
$ -547.03M$ -892.87M$ -2.10B$ -1.83B$ -126.61M
Per Share Metrics
Basic EPS
$ -10.54$ -18.37$ -50.15$ -53.83$ -3.97
Diluted EPS
$ -10.54$ -18.40$ -50.20$ -55.53$ -4.00
Weighted Average Shares Outstanding
51.89M 48.53M 41.93M 32.95M 31.65M
Weighted Average Shares Outstanding (Diluted)
51.89M 48.61M 42.00M 34.01M 31.87M
Currency in USD

Ginkgo Bioworks Holdings Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis